This record was last updated July 11, 2023 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
A multicenter single-arm phase 2 study to evaluate safety and efficacy of the total neoadjuvant therapy of short course radiation therapy followed by neoadjuvant oxaliplatin/fluorouracil-based chemotherapy (CAPOX) for cT2 rectal cancer